News

The randomized placebo-controlled, double-blinded FACT 2 study has enrolled 300 subjects who will be randomized 1:1 to administer carboplatin and paclitaxel plus fosbretabulin versus carboplatin and paclitaxel plus

Ganetespib is a potent inhibitor of heat shock protein 90 (Hsp90), a molecular chaperone which is required for the proper folding and activation of many cancer-promoting proteins. The

The assay, which provides a biomarker/ diagnostic to know the use of approved therapies for multiple cancer indications, is used as a personalized medicinal treatment in Acute Myelogenous

By using a slow-moving mist, Combivent Respimat can deliver the same active ingredients as Combivent inhalation aerosol, which is delivered in a metered dose inhaler, combivent MDI. Boehringer

The study, which has recruited 22 patients, is designed to demonstrate the safety and efficacy of APR-246 in treating patients with advanced cancers. Escalating doses of APR-246 were

Qsymia requires to be taken as an adjunct to a reduced-calorie diet and increased physical activity for obesity management by patients with improper body mass index along with

The company is planning an immediate release of the capsule in the US, which is being marketed under the brand name, Prevacid by Takeda. Wockhardt founder chairman and

Following the site inspection and documentation review, the SFDA has stated that the production plant is in compliance with the new 2010 GMP guidelines. Sinovac, which obtained production

The company will take into account many other details associated with the closure, such as evaluation of production commitments, decommissioning equipment and resource requirements. Boehringer stated that two